Exosomes derived from esophageal carcinoma cancer stem cells containing OGT target cytotoxic CD8+ cells, elevating the expression of PD-1, the receptor for PD-L1, which leads to suppression of immune activity, thus protecting cancer cells from the cytotoxic activity of the immune system (145). Here, OGT is linked to cancer.